Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citrulline is a non-essential α-amino acid naturally found in watermelon and produced in the body as part of the urea cycle. It is not incorporated into proteins but serves as a precursor to arginine and nitric oxide (NO), both of which are important for cardiovascular health. Citrulline supplementation increases plasma arginine levels more effectively than direct arginine supplementation due to better absorption and metabolism. Its main mechanisms include enhancing NO production (leading to vasodilation and improved blood flow), supporting muscle protein synthesis under catabolic conditions, exhibiting antioxidant and anti-inflammatory effects by modulating oxidative stress pathways such as NF-κB, aiding ammonia detoxification via the urea cycle, and serving as a biomarker for intestinal function. Clinically and nutraceutically it has been used or studied for athletic performance enhancement, erectile dysfunction (ED), hypertension (including pulmonary hypertension), sickle cell disease symptoms relief, heart disease support, fatigue reduction in various conditions including dementia/Alzheimer’s disease[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on citrulline.